Cargando…

Responsiveness to Ipratropium Bromide in Male and Female Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease

INTRODUCTION: Although the prevalence of chronic obstructive pulmonary disease (COPD) is similar between men and women, current evidence used to support bronchodilator therapy has been generated in therapeutic trials that have predominately enrolled male patients. Here, we determined whether there i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xuan, Obeidat, Ma'en, Zhou, Guohai, Leung, Janice M., Tashkin, Donald, Wise, Robert, Connett, John, Joubert, Philippe, Bossé, Yohan, van den Berge, Maarten, Brandsma, Corry-Anke, Nickle, David C., Hao, Ke, Paré, Peter D., Sin, Don D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440622/ https://www.ncbi.nlm.nih.gov/pubmed/28461224 http://dx.doi.org/10.1016/j.ebiom.2017.04.020

Ejemplares similares

The Overlap of Lung Tissue Transcriptome of Smoke Exposed Mice with Human Smoking and COPD
por: Obeidat, Ma’en, et al.
Publicado: (2018)

The Effect of Ipratropium Bromide with Violet Flower Extract, Ipratropium Bromide with Budesonide, and Ipratropium Bromide Alone on the Cuff-Leak of the Endotracheal Tube in Intubated ICU Patients
por: Hashemi, Seyed Taghi, et al.
Publicado: (2023)

Bromangiomas-ipratropium bromide–associated angiomas
por: Samlaska, Curt, et al.
Publicado: (2019)

Total particulate matter concentration skews cigarette smoke's gene expression profile
por: Dvorkin-Gheva, Anna, et al.
Publicado: (2016)

Rare causes of anisocoria: Ipratropium bromide and Angel’s trumpet
por: Ekici, Arzu, et al.
Publicado: (2021)

Transient anisocoria in a patient treated with nebulized ipratropium bromide
por: Pejic, Renato, et al.
Publicado: (2017)

Genetic regulation of gene expression of MIF family members in lung tissue
por: Florez-Sampedro, Laura, et al.
Publicado: (2020)

Unilateral mydriasis secondary to ipratropium bromide in a critically ill patient
por: Santana-Cabrera, Luciano, et al.
Publicado: (2012)

Bioequivalence study of ipratropium bromide inhalation aerosol using PBPK modelling
por: Zhang, Jisheng, et al.
Publicado: (2023)

Combination of ipratropium bromide and salbutamol in children and adolescents with asthma: A meta-analysis
por: Xu, Hongzhen, et al.
Publicado: (2021)

Sulfatase modifying factor 1 (SUMF1) is associated with Chronic Obstructive Pulmonary Disease
por: Weidner, Julie, et al.
Publicado: (2017)

Impact of Statins on Gene Expression in Human Lung Tissues
por: Lane, Jérôme, et al.
Publicado: (2015)

Use of inhaled ipratropium bromide to improve exercise-induced laryngeal obstruction cannot be recommended
por: Muralitharan, Praveen, et al.
Publicado: (2023)

Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial
por: Donohue, James F., et al.
Publicado: (2016)

Multi-omics highlights ABO plasma protein as a causal risk factor for COVID-19
por: Hernández Cordero, Ana I., et al.
Publicado: (2021)

Gene expression network analysis provides potential targets against SARS-CoV-2
por: Hernández Cordero, Ana I., et al.
Publicado: (2020)

Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials
por: Haney, Sarah, et al.
Publicado: (2007)

COPD patient satisfaction with ipratropium bromide/albuterol delivered via Respimat: a randomized, controlled study
por: Ferguson, Gary T, et al.
Publicado: (2013)

Ipratropium bromide is more effective than Salmeterol — Fluticason combination on O(2) saturation patients with COPD
por: Rezaie, Nader, et al.
Publicado: (2013)

The Effect of Statins on Blood Gene Expression in COPD
por: Obeidat, Ma’en, et al.
Publicado: (2015)

Whole Exome Re-Sequencing Implicates CCDC38 and Cilia Structure and Function in Resistance to Smoking Related Airflow Obstruction
por: Wain, Louise V., et al.
Publicado: (2014)

Efficacy and safety of eco-friendly inhalers: focus on combination ipratropium bromide and albuterol in chronic obstructive pulmonary disease
por: Panos, Ralph J
Publicado: (2013)

Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD
por: Bhattacharya, Amal, et al.
Publicado: (2016)

Compatible Stability and Aerosol Characteristics of Atrovent(®) (Ipratropium Bromide) Mixed with Salbutamol Sulfate, Terbutaline Sulfate, Budesonide, and Acetylcysteine
por: Chen, Yiting, et al.
Publicado: (2020)

Nebulized Ipratropium bromide protects against tracheal and bronchial secretion during bronchoscopy: A randomized controlled trial
por: Wang, Faping, et al.
Publicado: (2019)

Comparison of nebulised 3% hypertonic saline with ipratropium bromide in treatment of children with bronchiolitis: a randomized control trial
por: Naveed, Hina, et al.
Publicado: (2023)

Prioritization of candidate causal genes for asthma in susceptibility loci derived from UK Biobank
por: Valette, Kim, et al.
Publicado: (2021)

The genetics of smoking in individuals with chronic obstructive pulmonary disease
por: Obeidat, Ma’en, et al.
Publicado: (2018)

Refining Susceptibility Loci of Chronic Obstructive Pulmonary Disease with Lung eqtls
por: Lamontagne, Maxime, et al.
Publicado: (2013)

Functional imaging using computer methods to compare the effect of salbutamol and ipratropium bromide in patient-specific airway models of COPD
por: De Backer, LA, et al.
Publicado: (2011)

Unilateral pupillary mydriasis from nebulized ipratropium bromide: A false sign of brain herniation in the intensive care unit
por: Chaudhry, Priyanka, et al.
Publicado: (2014)

Effects of ipratropium bromide on the occurrence of postoperative respiratory complications in craniectomy patients with COPD: A nationwide multicenter retrospective study
por: Du, Zhuoying, et al.
Publicado: (2020)

Efficiency of Ipratropium Bromide and Albuterol Deposition in the Lung Delivered via a Soft Mist Inhaler or Chlorofluorocarbon Metered‐Dose Inhaler
por: MacGregor, TR, et al.
Publicado: (2016)

The Relation of Serum Myeloperoxidase to Disease Progression and Mortality in Patients with Chronic Obstructive Pulmonary Disease (COPD)
por: Park, Hye Yun, et al.
Publicado: (2013)

Effects of Ipratropium Bromide Combined with Traditional Chinese Medicine Intervention on the Pulmonary Function and Psychological Status of Patients with Chronic Obstructive Pulmonary Disease
por: Ye, Wen-Yi, et al.
Publicado: (2023)

Ipratropium Bromide/Salbutamol-Induced Acute Urinary Retention as a Result of Medication Error: A Case Report and Review of Cases in the Literature
por: Kubas, Mohammed Abdullah, et al.
Publicado: (2023)

Aerosol Characteristics and Physico-Chemical Compatibility of Combivent(®) (Containing Salbutamol and Ipratropium Bromide) Mixed with Three Other Inhalants: Budesonide, Beclomethasone or N-Acetylcysteine
por: Zhang, Rui, et al.
Publicado: (2020)

Compound Ipratropium Bromide plus Budesonide Inhalation in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Its Effect on Heparin-Binding Protein
por: Dong, Yuan, et al.
Publicado: (2022)

Recent advances in chronic obstructive pulmonary disease pathogenesis: from disease mechanisms to precision medicine
por: Brandsma, Corry‐Anke, et al.
Publicado: (2019)

A Potent Tartrate Resistant Acid Phosphatase Inhibitor to Study the Function of TRAP in Alveolar Macrophages
por: Boorsma, Carian E., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dhuicqsbkbr4fbifpi6i415aoc